An Unbiased View of Block Pain Receptors with Proleviate
Possessing recognized the palmitoylation motif of APLNR, we made a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation site in combination with morphine, can inhibit the event of NCP, including pain incidence, microglial activation, and inflammator